Details checkedStatus confirmedCheckedpublication

Mass Eye and Ear / EPFL Soft Auditory Brainstem Implant

Also known as: Soft auditory brainstem implant, MGB EPFL soft ABI, High-resolution soft ABI, Mass Eye and Ear soft ABI

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Preclinical

Status

Active

Target Gene

—

Route / Mode

Implantable soft auditory brainstem electrode array

Confidence

84%

Status Confidence

Status confirmed

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States, Switzerland

Population

preclinical, auditory-brainstem-implant, implantable-neuroprosthesis, central-auditory-prosthesis, thin-film-electrode-array

Trial IDs

Mechanism

Preclinical central-auditory neuroprosthesis using a soft, flexible, multilayer thin-film electrode construct designed to conform to the curved cochlear nucleus surface and provide higher-resolution brainstem stimulation than conventional stiff ABI arrays.

Indications

Hearing Loss Auditory Neuropathy Deafness

Notes

Adds next-generation central auditory prosthesis research to avoid treating auditory BCI/neurotech as only legacy ABI systems and general-purpose communication BCIs; the named collaborators are Mass Eye and Ear, Mass General Brigham, and EPFL. Not a marketed clinical product.

Evidence & Sources

2 structured sources

institution

Supports: canonicalName, aliases, company, modality, mechanism, indications, stage, status...

Open

publication

Supports: mechanism, keyEvents

IDs: 10.1038/s41551-025-01378-9

Open

Key Events

2025-05-15

Mass General Brigham described preclinical results for a soft auditory brainstem implant co-developed by Mass Eye and Ear and EPFL